免疫學市場：按藥物類別、按適應症、按分銷管道、按地區

2024年全球免疫學市場規模預計為965.1億美元，預計2031年將達2,161億美元，2024年至2031年複合年成長率為12.2%。

圖 1. 按地區分類的免疫學市場佔有率 (%)（2024 年）

免疫學是對免疫系統的研究，免疫系統保護身體免受細菌和病毒等外來入侵者的侵害。它涉及保護宿主免受感染和疾病的複雜細胞和分子機制。全球免疫學市場包括用於疾病診斷、藥物開發和研究與開發等各種目的的各種檢測、套件、儀器和軟體。針對醫院、研究所、製藥公司、生技公司等最終用戶。由於慢性病的增加、對個人化醫療的日益關注以及生物標記和伴同性診斷的日益採用，該市場正在顯著成長。然而，不斷上升的測試成本和監管問題給市場進入者帶來了挑戰。免疫測量技術的進步、生技藥品行業的成長以及準備的廣泛使用可能會在不久的將來推動免疫學市場的成長。

市場動態：

全球免疫學市場的成長是由癌症、糖尿病和心血管疾病等慢性疾病日益普及所推動的。根據世界衛生組織資料，2020年，慢性病將佔全球死亡人數的70%以上。老年人口的增加也將成為市場成長的動力，因為上述疾病的風險隨著老齡化而增加。對精準醫學的日益關注正在推動疾病管理中生物標記、伴同性診斷和免疫檢測測試的開發和採用。因此，預計在預測期內對免疫學相關產品的需求將會增加。然而，與高級測試相關的高成本可能會帶來重大挑戰，特別是在價格敏感的新興市場。新產品核可的嚴格監管程序也減緩了市場進入速度。研究活動正在增加，特別是在癌症免疫學和免疫治療領域，這可能會帶來利潤豐厚的商機。檢測開發的持續技術進步也可能擴大免疫學產品的應用。

本研究的主要特點

• 該報告對全球免疫學市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 該報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球免疫學市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 免疫學全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於全球免疫學市場分析的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行概述
• 一致的機會地圖 (COM)

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球免疫學市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章 全球免疫學市場，依藥物類別，2019-2031（十億美元）

• 介紹
• 單株抗體（mAb）
• 融合蛋白
• 免疫抑制劑
• 多株抗體(pAb)
• 其他

第6章 全球免疫學市場，依指標分類，2019-2031 年（十億美元）

• 介紹
• 類風濕性關節炎
• 乾癬性關節炎
• 斑塊型乾癬
• 僵直性脊椎炎
• 發炎性腸道疾病
• 預防器官排斥
• 其他

第 7 章 全球免疫學市場，依通路分類，2019-2031 年（十億美元）

• 介紹
• 醫院藥房
• 零售藥房
• 網路藥房

第8章全球免疫學市場，按地區，2019-2031（十億美元）

• 介紹
• 拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 東南亞國協
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • 波灣合作理事會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭格局

• 公司簡介
  • AbbVie Inc.
  • Johnson &Johnson
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck &Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB SA
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

第10章分析師建議

• 升起和降落
• 綜合機會圖

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global immunology market is estimated to be valued at USD 96.51 Bn in 2024 and is expected to reach USD 216.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

Figure 1. Immunology Market Share (%), By Region, 2024

Immunology is the study of the immune system, which protects the body from foreign invaders like bacteria and viruses. It involves complex cellular and molecular mechanisms that defend the host from infection or disease. Global immunology market encompasses various assays, kits, instruments and software that are used for various purposes like disease diagnosis, drug development and research activities. It caters to end users like hospitals, research institutes, pharmaceutical and biotechnology companies. The market has witnessed significant growth due to increasing prevalence of chronic diseases, rising focus on personalized medicine and growing adoption of biomarkers and companion diagnostics. However, high costs of tests and regulatory issues can pose challenges to market players. The advancements in immunoassay technologies, growing biologics industry, and popularity of poised can drive the immunology market growth in the near future.

Market Dynamics:

Global immunology market growth is driven by increasing prevalence of chronic diseases like cancer, diabetes and cardiovascular disorders. According to the data from WHO, chronic diseases accounted for over 70% of all deaths globally in 2020. Growing geriatric population can also drive the market growth as age increases the risk of above-mentioned conditions. Rising focus on precision medicine has bolstered the development and adoption of biomarkers, companion diagnostics and immunoassay tests in disease management. This is expected to boost demand for immunology products over the forecast period. However, high costs associated with advanced tests can pose significant challenges, especially in price-sensitive developing markets. Stringent regulatory processes for new product approvals can also delay market entry for players. Rising research activities especially in the fields of cancer immunology and immunotherapy can present lucrative opportunities. Continuous technological advancements in assay development can also expand the applications of immunology products.

Key Features of the Study:

• This report provides in-depth analysis of the global immunology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immunology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corporation, Beckman Coulter Inc, Danaher Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market.

Detailed Segmentation-

• By Drug Class
  • Monoclonal Antibody (mAb)
  • Fusion Proteins
  • Immunosuppressants
  • Polyclonal Antibody (pAb)
  • Others
• By Disease Indication
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Immunology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Immunology Market, By Drug Class, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Monoclonal Antibody (mAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Fusion Proteins
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Immunosuppressants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Polyclonal Antibody (pAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Immunology Market, By Disease Indication, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Psoriatic Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Plaque Psoriasis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ankylosing Spondylitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Inflammatory Bowel Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Prophylaxis of Organ Rejection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Immunology Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Immunology Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact